RANCHO SANTA FE BIO

rancho-santa-fe-bio-logo

Rancho Santa Fe Bio is a cardiovascular therapeutics company that develops cardiovascular drugs intended to slow the progression of calcification in patients with aortic valve stenosis.

#People #Website #More

RANCHO SANTA FE BIO

Social Links:

Industry:
Biotechnology Health Care Product Design Therapeutics

Founded:
2019-01-01

Address:
Rancho Santa Fe, California, United States

Country:
United States

Website Url:
http://www.rsfbio.com

Total Employee:
1+

Status:
Active

Contact:
(858)-205-5091

Email Addresses:
[email protected]



Current Advisors List

randy-berholtz_image

Randy Berholtz Chairman @ Rancho Santa Fe Bio
Board_member

Current Employees Featured

laura-lewerentz-juziuk_image

Laura Lewerentz-Juziuk
Laura Lewerentz-Juziuk Co-Founder and COO @ Rancho Santa Fe Bio
Co-Founder and COO
2017-01-01

randy-berholtz_image

Randy Berholtz
Randy Berholtz CEO @ Rancho Santa Fe Bio
CEO
2020-01-01

Founder


laura-lewerentz-juziuk_image

Laura Lewerentz-Juziuk

Official Site Inspections

http://www.rsfbio.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Rancho Santa Fe Bio"

Rsfbio

Rancho Santa Fe Bio, Inc ("RSF Bio") is a clinical-stage, cardiovascular therapeutics platform company, based in San Diego, California. Calcific aortic Valve Stenosis (CAVS) affects 3% of โ€ฆSee details»

About - Rsfbio

RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. Below is a description of our leadership team, scientific advisory board, and board of directors.See details»

Rancho Santa Fe Bio - Crunchbase Company Profile

Contact Email [email protected] Phone Number (858)-205-5091 Rancho Santa Fe Bio is a cardiovascular therapeutics company that develops cardiovascular drugs intended to slow the progression of calcification in patients with aortic valve โ€ฆSee details»

Dr. Daniel Bloomfield - rsfbio.com

An Oxford Rhodes Scholar and Cardiologist, Dr. Bloomfield's career spans years of effective collaboration across a worldwide organization, partnership with the FDA, and most recently programmatic strategy in China across therapeutic โ€ฆSee details»

Rancho Santa Fe Bio, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Rancho Santa Fe Bio, Inc. of Rancho Santa Fe, CA. Get the latest business insights from Dun & Bradstreet.See details»

Rancho Santa Fe Bio, Inc. | LinkedIn

Rancho Santa Fe Bio, Inc. is a clinical-stage cardiovascular therapeutics company based in San Diego, California. Rancho Santa Fe Bio, Inc. | 148 followers on LinkedIn.See details»

Rancho Santa Fe Bio Company Profile 2024: Valuation, Funding ...

Developer of cardiovascular therapeutics platform designed to focus on the development of novel treatments for acute, chronic and debilitating cardiovascular diseases.See details»

Rancho Santa Fe Bio - Products, Competitors, Financials, โ€ฆ

Rancho Santa Fe Bio primarily serves the healthcare industry, specifically the sector dealing with cardiovascular diseases. It was founded in 2019 and is based in Rancho Santa Fe, California.See details»

Rancho Santa Fe Bio, Inc. Enters into Worldwide โ€ฆ

SAN DIEGO and PARIS, June 17, 2021 (GLOBE NEWSWIRE) -- Rancho Santa Fe Bio, Inc. (โ€œRSF Bioโ€ or the โ€œCompanyโ€), a San Diego, California-based clinical-stage cardiovascular platform company, today...See details»

Rancho Santa Fe Bio, Inc. | VentureRadar

RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. Ataciguat, a nitric oxide-independent soluble guanylate cyclase activator, is being โ€ฆSee details»

Rancho Santa Fe Bio - Overview, News & Similar companies

View Rancho Santa Fe Bio (www.rsfbio.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License ...

Jun 17, 2021ย ยท RSF Bio is a San Diego, California clinical stage cardiovascular platform company. RSF Bio has exclusively licensed from the Mayo Clinic and from Sanofi Ataciguat for the โ€ฆSee details»

Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License ...

SAN DIEGO and PARIS, June 17, 2021 (GLOBE NEWSWIRE) -- Rancho Santa Fe Bio, Inc. (โ€œRSF Bioโ€ or the โ€œCompanyโ€), a San Diego, California-based clinical-stage cardiovascular โ€ฆSee details»

Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive

Jun 17, 2021ย ยท RSF Bio is a San Diego, California clinical stage cardiovascular platform company. RSF Bio has exclusively licensed from the Mayo Clinic and from Sanofi Ataciguat for the โ€ฆSee details»

Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License ...

Jun 17, 2021ย ยท RSF Bio is a San Diego, California clinical stage cardiovascular platform company. RSF Bio has exclusively licensed from the Mayo Clinic and from Sanofi Ataciguat for the โ€ฆSee details»

Conferences - Rsfbio

For questions regarding news, information, and conference attendance, please feel free to contact the Rancho Santa Fe Bio team.See details»

Next Gen Technology - rsfbio.com

We are looking to expand our product platform by exploring the development of additional indications (including orphan indications), developing a biomarker to be able to identify earlier โ€ฆSee details»

Ataciguat - Rancho Santa Fe Bio - AdisInsight - Springer

Jul 28, 2024ย ยท If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with โ€ฆSee details»

Press Releases - Rsfbio

Jun 17, 2021ย ยท For questions regarding press releases, please feel free to contact the Rancho Santa Fe Bio team.See details»

The Science Behind Ataciguat - rsfbio.com

Ataciguat, a nitric oxide-independent soluble guanylate cyclase activator, is being developed by RSF Bio for the treatment of moderate CAVS.See details»